Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Jayasena

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|October 29, 2010
Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrheaC N Jayasena, G M K Nijher, A Abbara, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteersC N Jayasena, A N Comninos, G M K Nijher, et al.
Human Reproduction (Oxford, England)|September 25, 2016
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriageC N Jayasena, A Abbara, A N Comninos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2014
Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriageC N Jayasena, A Abbara, C Izzi-Engbeaya, et al.
British Journal of Pharmacology|September 1, 2012
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstemKel Beale, J V Gardiner, G A Bewick, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|October 29, 2010
Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrheaC N Jayasena, G M K Nijher, A Abbara, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteersC N Jayasena, A N Comninos, G M K Nijher, et al.
Human Reproduction (Oxford, England)|September 25, 2016
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriageC N Jayasena, A Abbara, A N Comninos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2014
Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriageC N Jayasena, A Abbara, C Izzi-Engbeaya, et al.
British Journal of Pharmacology|September 1, 2012
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstemKel Beale, J V Gardiner, G A Bewick, et al.
Pageof 2